InvestorsHub Logo
Followers 21
Posts 865
Boards Moderated 0
Alias Born 02/09/2019

Re: jessellivermore post# 263791

Wednesday, 04/08/2020 8:50:25 AM

Wednesday, April 08, 2020 8:50:25 AM

Post# of 430347
Doc JL...
I think you have me on ignore. So, others can hear me out.
The life saving factor of Vascepa ( new indication) must be taken into consideration. My questions is this: did the judge allow anything pertaining to Reduce-it into the trial?

Everyone on the planet knows that any generic approved will infringe on this new patent. How or why should this be overlooked? Do we all realize what this does to future innovation?

I agree with the good doctor. Some how and some way, this indication must be protected.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News